“I’m 78 and my youthful skin is all down to this £10 Boots anti-ageing serum” The No7 anti-ageing serum is usually £34.95 and has been reduced to £10 as part of Boots' weekly £10 Tuesday offers Chronicle Live · May 9, 2023
Pharmacies in England to offer prescriptions for seven conditions amid surgery crisis Proposal is designed to free up 15m GP appointments over the next two years The Guardian - UK · May 8, 2023
No. 1 Undervalued Stock in May Leading healthcare company McKesson’s (MCK) stock looks undervalued at its current price and could be an excellent pick for value investors. Let’s look at some of MCK’s key metrics. StockNews.com · May 8, 2023
Warning of more pharmacy closures ‘unless Government provides urgent funding’ Government proposals to improve access to primary care are expected on Tuesday. The Independent UK · May 8, 2023
The Bottom of the Barrel: The Worst Drug Store Stock for Investors MedAvail Holdings’ (MDVL) net loss widened by nearly 9% in fiscal 2022. The company has been taking some measures to achieve profitability, but it still looks far away. Amid this backdrop, investors could consider avoiding the stock. Read more…. StockNews.com · May 5, 2023
FDA weighing 1st over-the-counter birth control pill U.S. health regulators are weighing the first-ever request to make a birth control pill available without a prescription The Independent UK · May 5, 2023
Shield Therapeutics shareholders told to reject £46.1m takeover offer One of the firm's long term shareholders has tabled an offer Birmingham Post · May 5, 2023
Explosion rips roof off pharmaceutical plant; worker missing Officials say an explosion at a pharmaceutical plant in Massachusetts left one worker missing and sent four people to the hospital as a precaution The Independent UK · May 4, 2023
Drug testing venture Cansford Laboratories acquired by Phenna Group Lexington Corporate Finance advised the shareholders of Cansford on the sale Birmingham Post · May 4, 2023
Certus Biomedical relocates to meet growing demand with plans to double workforce The Cornwall-based medical equipment service and supply company hopes to double its team in the next two years Birmingham Post · May 4, 2023
AMD Says Delayed 7040HS 'Phoenix' Laptop CPUs Are Now Shipping to OEMs AMD says that it has made its own self-imposed deadline to ship its Ryzen 7040HS laptop processors, also known as the "Phoenix" series, to OEMs. Tom’s Hardware · May 2, 2023
High Court hearing to begin over hormone pregnancy test blamed for birth defects More than 200 people are launching a legal case after claiming to be caused harm by the drug Primodos, which was given to women to test if they were pregnant from the 1950s until the late 1970s Wales Online · May 2, 2023
Attorney General Ken Paxton to investigate COVID-19 vaccine makers Long an opponent of vaccine and mask mandates, the Republican said pharmaceutical companies may have misrepresented data. Pfizer strongly disagrees. The Texas Tribune · May 2, 2023
Recruitment of drug inspectors: Karnataka HC directs govt to redo selection list BENGALURU: Finding fault with the authorities with regards to insertion of “18 months experience clause” at a belated stage in the eligibility criteria pertaining to selection of Drug Inspectors, the Karnataka high court has quashed the entire selection list published in November 2020. The Times of India · Apr 29, 2023
The Independent UK · Apr 29, 2023 Frustration grows over wait on OxyContin maker's settlement More than a year after the maker of OxyContin reached a tentative settlement over the toll of opioids, the money isn't flowing yet
StockNews.com · Apr 28, 2023 Healthy Returns: This A Rated Healthcare Stock Is a Must-Watch for May Given the pharmaceutical industry’s robust growth prospects, drug-maker Neurocrine Biosciences’ (NBIX) stock is worth watching ahead of its first-quarter earnings next week. Read on….
The Independent UK · Apr 27, 2023 Vermont passes bills aimed at protecting abortion pills The Vermont Legislature has passed reproductive and gender-affirming health care bills with a late addition aimed at protecting access to a medication widely used in abortions — even if the U.S. Food and Drug Administration withdraws its approval of mifepristone
StockNews.com · Apr 27, 2023 A Prescription for Success: Check Out This Strong Pharmaceutical Stock This Week Leading biotech company Regeneron Pharmaceuticals (REGN) has exhibited robust financial growth in recent years. With the biotech industry’s promising prospects, this stock might be a solid portfolio addition now. Read on….
The Guardian - UK · Apr 27, 2023 UK and Europe are falling behind US and China in biotech, says AstraZeneca boss Pascal Soriot says decline in startups across Europe differs markedly from ‘explosion’ of firms and clinical trials in China
Birmingham Post · Apr 27, 2023 Shield Therapeutics hails US market progress and mulls stateside listing The Gateshead company said additional losses were to be expected as it carries out a plan to target US iron deficiency treatment demand
France 24 · Apr 26, 2023 The long and winding history of the war on abortion drugs Along with the stethoscope and camembert cheese, mifepristone may be one of France’s greatest inventions. It’s one of two drugs taken for medical abortions, along with misoprostol, and has been making headlines in the US, where a Texas judge issued a ruling to ban it nationwide. FRANCE 24 takes a…
The Guardian - UK · Apr 26, 2023 New CBI boss says she is ‘profoundly sorry’ to women let down by group Rain Newton-Smith’s tweets came on day she became director general at Confederation of British Industry
Birmingham Post · Apr 26, 2023 Smith & Nephew reports strong first quarter growth with £44m sales uplift Hull-founded firm enjoying double digit expansion in largest established market as it awaits consent for East Yorkshire build
ABC News · Apr 26, 2023 Regional pharmacists say 60-day medication changes could 'break' overwhelmed system The extension of dispensing timelines on hundreds of medications will lead to pharmacies closing and impact healthcare access, according to pharmacists in regional NSW.
The Independent UK · Apr 25, 2023 Drug for rare form of Lou Gehrig’s disease OK'd by FDA U.S. health regulators have approved a first-of-a-kind drug for a rare form of Lou Gehrig’s disease